Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vikas Lifecare Limited ( (IN:VIKASLIFE) ) has provided an update.
Vikas Lifecare Limited’s board has approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, as well as for the quarter and nine months ended December 31, 2025, following review by the audit committee and limited review by statutory auditors. The company also cleared a plan to seek shareholders’ consent via an addendum to an existing postal ballot notice to authorize a range of transactions, including related party dealings, investments, loans, guarantees, securities provision, and creation of charges or mortgages, aimed at providing greater operational and financial flexibility for routine business activities.
The board meeting, held at the company’s Delhi registered office on April 21, 2026, formalized these approvals as part of ongoing compliance with SEBI’s listing regulations. The moves underscore Vikas Lifecare’s emphasis on regulatory adherence and on securing broader shareholder backing for financial arrangements that can support future business requirements and day-to-day operational efficiency.
More about Vikas Lifecare Limited
Vikas Lifecare Limited is an India-based company listed on the NSE and BSE, operating manufacturing facilities in Rajasthan and Karnataka with its registered office in Delhi. The company is engaged in industrial and consumer-focused businesses, and caters to both domestic and exchange-listed stakeholders through its diversified operations and compliance-driven governance framework.
Average Trading Volume: 844,476
Technical Sentiment Signal: Sell
Current Market Cap: 3.03B INR
For detailed information about VIKASLIFE stock, go to TipRanks’ Stock Analysis page.